Your browser doesn't support javascript.
loading
[Interference of Exogenous Insulin on Insulin Detection Test by Electrochemiluminescence Immunoassay].
Zhang, Mei; Zhou, Jun; Yang, Li-Dan; Gui, Xue-Mei; Huang, Jun; Luo, Kai-Hong; Huang, Heng-Jian.
Afiliação
  • Zhang M; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Zhou J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Yang LD; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Gui XM; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Huang J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Luo KH; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Huang HJ; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 49(6): 924-928, 2018 Nov.
Article em Zh | MEDLINE | ID: mdl-32677406
ABSTRACT

OBJECTIVE:

To explore the interference of exogenous insulin therapy on insulin detection test by electrochemical luminescence immunoassay (ECLIA).

METHODS:

Insulin level was determined by ECLIA. According to the requirements of EP7-A2 of American Society for Clinical Laboratory Standards Institute Standards, paired difference experiment was conducted to evaluate the interference of 8 kinds of exogenous insulin on insulin detection, dose effect experiment was conducted to determine the relationship between exogenous insulin concentration and interference degree.

RESULTS:

When the interfering substance concentrations were ≤250 µU/mL, Gansulin NⓇ, Gansulin RⓇ, Humulin RⓇ,Novolin RⓇ and LantusⓇ all showed linear positive interference, while LevemirⓇ showed a linear negative interference in high concentrations insulin and non-interfering in low concentrations insulin, HumalogⓇ and Novo RapidⓇ showed non-interference in insulin detection.

CONCLUSIONS:

The use of different exogenous insulin may have different interference on insulin measurement, which need laboratorians and physicians notice to avoid misdiagnosis.
Palavras-chave
Buscar no Google
Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: Zh Revista: Sichuan Da Xue Xue Bao Yi Xue Ban Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China
Buscar no Google
Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: Zh Revista: Sichuan Da Xue Xue Bao Yi Xue Ban Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China